欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

激素难治性前列腺癌的分子决定因素

Molecular Determinants of Hormone Refractory Prostate Cancer

作者:Choudhury, A. 加工时间:2015-08-05 信息来源:科技报告(AD) 索取原文[35 页]
关键词:基因;荷尔蒙;体内的分析;前列腺癌
摘 要:We have performed a high throughput, in vivo genetic screen to identify kinases that permitted androgen-dependent transformed prostate epithelial cells (LHSR-AR cells) to form tumors in female animals. In addition to known prostate cancer oncogenes, Never In Mitosis A (NIMA) related kinase 6 (NEK6) reproducibly yielded androgen-independent tumors in female mice. NEK6 can confer castration resistance to established tumors in male mice, and inactivating its expression can restore sensitivity to castration. Castration- resistant tumors generated through NEK6 overexpression are predominantly squamous in histology and AR-negative, and NEK6 does not activate AR signaling. NEK6 overexpression leads to phosphorylation of RPS6KB1 and SGK1, and these two genes along with a novel identified substrate, FOXJ2, are essential for NEK6- mediated androgen-independent tumor formation. NEK6 is located on a region of recurrent copy number gain on chromosome 9q33.3 in human prostate cancer, and NEK6 overexpression in tumor microarrays and the TCGA data set correlates with more aggressive disease. NEK6 and its downstream effectors are thus potential novel therapeutic targets in CRPC.
© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服